Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study.
Focal radiation to the brain improves survival in HER2-positive breast cancer patients with brain involvement, with manageable side effects.
We evaluated survival across treatment sequences within a real-world cohort. Focal cranial RT was independently associated with longer survival, and toxicity was manageable.
What the study was
- Study design
- Retrospective cohort study
- Population
- We evaluated survival across treatment sequences within a real-world cohort.
- Sample size
- 101
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Clin Transl Radiat Oncol
Why it surfaced
Retrospective cohort study with a PubMed abstract reviewed; the 7/10 score reflects conservative novelty, relevance, design-quality, and population/unmet-need assessment.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.